• OPEN AN ACCOUNT
Indian Indices
Sensex
74,616.00 300.39
( 0.40%)
Global Indices
Nasdaq
52,191.76 549.28
(1.06%)
Dow Jones
7,764.37 24.43
(0.32%)
Hang Seng
65,489.63 1,063.68
(1.65%)
Nikkei 225
10,840.19 115.33
(1.08%)
Forex
USD-INR
95.08 -0.14
(-0.15%)
EUR-INR
106.23 -0.27
(-0.26%)
GBP-INR
125.74 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.23%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Shukra Pharmaceuticals consolidated net profit rises 1158.25% in the June 2026 quarter
Aug 12,2026
Net profit of Shukra Pharmaceuticals rose 1158.25% to Rs 12.96 crore in the quarter ended June 2026 as against Rs 1.03 crore during the previous quarter ended June 2025. Sales rose 336.36% to Rs 23.52 crore in the quarter ended June 2026 as against Rs 5.39 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales23.525.39 336
OPM %81.3824.49 -
PBDT19.252.16 791
PBT18.171.37 1226
NP12.961.03 1158